Cargando…

Chimeric VLPs Bearing VP60 from Two Serotypes of Rabbit Haemorrhagic Disease Virus Are Protective against Both Viruses

The VP60 capsid protein from rabbit haemorrhagic disease virus (RHDV), the causative agent of one of the most economically important disease in rabbits worldwide, forms virus-like particles (VLPs) when expressed using heterologous protein expression systems such as recombinant baculovirus, yeasts, p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalton, Kevin P., Alvarado, Carmen, Reytor, Edel, del Carmen Nuñez, Maria, Podadera, Ana, Martínez-Alonso, Diego, Alonso, Jose Manuel Martin, Nicieza, Ines, Gómez-Sebastián, Silvia, Dalton, Romy M., Parra, Francisco, Escribano, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472679/ https://www.ncbi.nlm.nih.gov/pubmed/34579243 http://dx.doi.org/10.3390/vaccines9091005

Ejemplares similares

Molecular characterisation of virulence graded field isolates of myxoma virus
por: Dalton, Kevin P, et al.
Publicado: (2010)

Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs
por: Shepley-McTaggart, Ariel, et al.
Publicado: (2021)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

Reverse Genetics System for Rabbit vesivirus
por: Álvarez, Ángel L., et al.
Publicado: (2020)

Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
por: Swanson, Jessica, et al.
Publicado: (2021)

Epizootic Haemorrhagic Disease Virus Serotype 8 in Tunisia, 2021
por: Sghaier, Soufien, et al.
Publicado: (2022)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes
por: Jyothi, Shiva J., et al.
Publicado: (2020)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co‐delivered with norovirus VLPs
por: Malm, M., et al.
Publicado: (2017)

Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus
por: Fontana, Diego, et al.
Publicado: (2021)

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
por: Kanai, Yuta, et al.
Publicado: (2014)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
por: Fay, Petra C., et al.
Publicado: (2021)

Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae
por: Encinas, Paloma, et al.
Publicado: (2011)

VLPs Derived from the CCMV Plant Virus Can Directly Transfect and Deliver Heterologous Genes for Translation into Mammalian Cells
por: Villagrana-Escareño, María V., et al.
Publicado: (2019)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

Regulation of Ebola virus VP40 matrix protein by SUMO
por: Baz-Martínez, Maite, et al.
Publicado: (2016)

Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells
por: Grataitong, Khwanthana, et al.
Publicado: (2021)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1
por: Alam, SM Sabbir, et al.
Publicado: (2013)

Evolutionary Analysis of Structural Protein Gene VP1 of Foot-and-Mouth Disease Virus Serotype Asia 1
por: Zhang, Qingxun, et al.
Publicado: (2015)

Genotyping of rabbit hemorrhagic disease virus detected in diseased rabbits in Egyptian Provinces by VP60 sequencing
por: Erfan, Ahmed M., et al.
Publicado: (2020)

Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge
por: Rojas, José Manuel, et al.
Publicado: (2021)

Variant Rabbit Hemorrhagic Disease Virus in Young Rabbits, Spain
por: Dalton, Kevin P., et al.
Publicado: (2012)

Engineering Responses to Amino Acid Substitutions in the VP0- and VP3-Coding Regions of PanAsia-1 Strains of Foot-and-Mouth Disease Virus Serotype O
por: Bai, Xing-Wen, et al.
Publicado: (2019)

Increased Clinical Signs and Mortality in IFNAR((−/−)) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype
por: Attoui, Houssam, et al.
Publicado: (2023)

Visualization of the African swine fever virus infection in living cells by incorporation into the virus particle of green fluorescent protein-p54 membrane protein chimera
por: Hernaez, Bruno, et al.
Publicado: (2006)

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020)

Rabbit hemorrhagic disease virus VP60 protein expressed in recombinant swinepox virus self-assembles into virus-like particles with strong immunogenicity in rabbits
por: Liu, Changjin, et al.
Publicado: (2022)

Protective Immunity Elicited by VP1 Chimeric Antigens of Bacterial Ghosts against Hand-Foot-and-Mouth Disease Virus
por: Gong, Saisai, et al.
Publicado: (2020)

Exploiting the Yeast L-A Viral Capsid for the In Vivo Assembly of Chimeric VLPs as Platform in Vaccine Development and Foreign Protein Expression
por: Powilleit, Frank, et al.
Publicado: (2007)

An Equine Herpesvirus Type 1 (EHV-1) Expressing VP2 and VP5 of Serotype 8 Bluetongue Virus (BTV-8) Induces Protection in a Murine Infection Model
por: Ma, Guanggang, et al.
Publicado: (2012)

A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity
por: Dong, Hu, et al.
Publicado: (2021)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
por: Zhu, Deanna R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nojes4p411fctn1rvukhpamftd